UGT1A3: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
No edit summary |
||
| Line 11: | Line 11: | ||
== Research == | == Research == | ||
Research into the UGT1A3 enzyme and its associated gene continues to be an active area of study. This research has the potential to improve our understanding of drug metabolism and toxicity, and may ultimately lead to the development of personalized medicine strategies based on an individual's UGT1A3 genotype. | Research into the UGT1A3 enzyme and its associated gene continues to be an active area of study. This research has the potential to improve our understanding of drug metabolism and toxicity, and may ultimately lead to the development of personalized medicine strategies based on an individual's UGT1A3 genotype. | ||
== See also == | == See also == | ||
| Line 19: | Line 17: | ||
* [[Gilbert's syndrome]] | * [[Gilbert's syndrome]] | ||
* [[Drug metabolism]] | * [[Drug metabolism]] | ||
[[Category:Enzymes]] | [[Category:Enzymes]] | ||
[[Category:Genes]] | [[Category:Genes]] | ||
Latest revision as of 16:21, 19 November 2024
UGT1A3 is an enzyme that is encoded by the UGT1A3 gene in humans. It is part of the UDP-glucuronosyltransferase (UGT) family, which is involved in the metabolism of a wide range of endogenous and exogenous compounds.
Function[edit]
The UGT1A3 enzyme is primarily found in the liver, where it plays a crucial role in the detoxification and elimination of potentially harmful substances. It does this by catalyzing the transfer of glucuronic acid, a process known as glucuronidation, to a variety of substrates including drugs, environmental toxins, and endogenous compounds such as bilirubin and steroids.
Clinical significance[edit]
Alterations in the UGT1A3 gene can lead to changes in the function of the UGT1A3 enzyme, which can have significant clinical implications. For example, mutations in the UGT1A3 gene have been associated with Gilbert's syndrome, a benign condition characterized by mild, intermittent jaundice due to decreased bilirubin glucuronidation.
In addition, variations in the UGT1A3 gene can influence the metabolism and efficacy of certain drugs. For instance, individuals with certain UGT1A3 variants may require lower doses of drugs that are metabolized by this enzyme to avoid adverse effects.
Research[edit]
Research into the UGT1A3 enzyme and its associated gene continues to be an active area of study. This research has the potential to improve our understanding of drug metabolism and toxicity, and may ultimately lead to the development of personalized medicine strategies based on an individual's UGT1A3 genotype.
See also[edit]
